Sefadol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sefadol

Property Description
Active Ingredient Cefadroxil
Pharmacological Class Antibiotic (First-Generation Cephalosporin)
Forms Capsules, Tablets, Powder for Oral Suspension
General Purpose To combat bacterial infections
Origin Synthetic

What Type of Medicine is Sefadol (Cefadroxil)?

Sefadol is a prescription-only antibacterial agent whose active substance is Cefadroxil, categorized as an antibiotic within the cephalosporin class. This medication is specifically designated as a first-generation cephalosporin, a synthetic type of beta-lactam drug. The cephalosporin group is a cornerstone of antimicrobial therapy, important for treating various infections. This classification identifies Sefadol's role as an agent designed for targeted action against bacterial infections.


Composition and Available Oral Forms

The core of Sefadol is its single-ingredient composition featuring the active pharmaceutical ingredient Cefadroxil. Sefadol is often distinguished by its specialized powder for oral suspension formulation, making it particularly suitable for pediatric patients who may have difficulty swallowing tablets. The primary use for this compound is the treatment of infections caused by susceptible microorganisms. This confirms that the medicine's core purpose is targeted against specific types of harmful bacteria. The availability of these distinct oral forms ensures the medication can be administered effectively, relying on the primary oral administration route.


What is the General Purpose of This Antibacterial Agent?

The general purpose of Sefadol is to combat bacterial infections by exerting a decisive bactericidal effect on susceptible pathogens in the body. This means the medication actively works to kill the invading bacteria rather than just slowing their growth, achieving this by interfering with the vital process of bacterial cell wall synthesis. By directly eliminating the source of the ailment, Sefadol helps the body recover and brings relief from the general discomfort and systemic symptoms associated with an active bacterial infection, such as when treating a recognized respiratory tract infection.

Regulatory References

  1. NIH Cephalosporins Overview

What side effects are possible with Sefadol?

Possible Side Effects and Safety Information

The safety profile of Sefadol is formally documented based on reports collected through clinical studies and post-market surveillance. Adverse reactions are classified according to their frequency and the specific body system affected (System-Organ-Class).

Adverse Reactions by Frequency

Official regulatory documents classify side effects into the following categories based on their observed rate of occurrence:

  • Very Common: Affects 1 or more in 10 patients.
  • Common: Affects 1 or more in 100, but less than 1 in 10 patients. These often include gastrointestinal disturbances such as diarrhea and nausea.
  • Uncommon: Affects 1 or more in 1,000, but less than 1 in 100 patients.
  • Rare: Affects 1 or more in 10,000, but less than 1 in 1,000 patients.
  • Very Rare: Affects less than 1 in 10,000 patients.

Serious and Clinically Significant Risks

Certain adverse reactions are designated as serious due to their potential for severe patient outcomes. These events require immediate clinical attention and are highlighted in the official labeling. Serious risks include severe hypersensitivity reactions, such as anaphylaxis or angioedema, and severe skin reactions like Stevens-Johnson syndrome (SJS). Additionally, Clostridium difficile-associated diarrhea (CDAD) and related colitis are documented as significant risks associated with antibiotic exposure.

Safety Restrictions and Monitoring

Sefadol is contraindicated in patients with a known history of hypersensitivity or severe allergic reactions to Sefadol, any of its components, or to the class of cephalosporin antibiotics. Official documents mandate caution for specific populations; for example, dose monitoring and potential adjustment are necessary for elderly patients and patients with pre-existing renal impairment, reflecting a higher risk profile in these groups. Use must be discontinued immediately if severe allergic reactions or C. difficile symptoms appear.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Sefadol (Cefadroxil) overdose emphasizes the potential for both gastrointestinal and central nervous system effects. Documented overdose presentations may include general symptoms such as nausea, vomiting, and dose-dependent gastrointestinal distress. More severe exposures are associated with signs of CNS toxicity, including seizures and altered consciousness, which are the primary serious outcomes defined in the official labeling. A critical population-specific note highlights that individuals with markedly impaired renal function face an increased risk of severe CNS toxicity due to drug accumulation when elimination is compromised.

Emergency Actions and Supportive Management

In the event of a suspected overdose, regulatory authorities mandate that patients must seek emergency medical attention immediately or call the Poison Help line. Urgent medical help is required if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Management of Cefadroxil overdosage is strictly symptomatic and supportive, as no specific antidote is known. Procedural steps documented for severe cases include the possible use of hemodialysis for drug removal, particularly when accumulation has occurred.

Therapeutic Uses of Sefadol

Sefadol (Cefadroxil) generally provides therapeutic support and is applied in addressing conditions presenting with systemic or localized discomfort, which contributes to easing the overall symptom load. The medication is commonly used to help with infections of the skin, throat, tonsils, and urinary tract. It is relevant for easing symptoms related to physical discomfort and inflammatory states across these therapeutic domains.


Key Therapeutic Applications and Relief

This antibiotic is commonly used across conditions characterized by periods of heightened symptoms, such as acute urinary tract infections (UTIs) and streptococcal throat infections. It helps address symptom clusters that may become intense or disruptive, including painful urination, urgent frequency, sore throat, and fever.

In clinical scenarios, it is applied for skin and skin structure infections where additional symptomatic support is needed for manifestations like redness and localized pain. Furthermore, Sefadol is considered relevant as part of symptomatic management applied in preventing specific serious infections, such as bacterial endocarditis, in at-risk patients undergoing necessary procedures. It helps ease the overall symptom burden, and may assist with supporting general well-being during symptomatic phases.

“It is commonly used to help with infections of the skin, throat, tonsils, and urinary tract.”


Quick Fact: Relief for Urinary Discomfort

Quick Fact: Relief for Urinary Discomfort

Sefadol is applied in contexts involving heightened physiological activity and functional stress, where it is used for managing symptoms that may become disruptive during flare-ups, particularly dysuria (painful urination) and urinary urgency.

Regulatory References

  1. NIH MedlinePlus Drug Information on Cefadroxil

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Sefadol (Cefadroxil)

This information is based strictly on authoritative government regulatory documents, outlining the official population eligibility and non-eligibility for Sefadol, which contains the active ingredient Cefadroxil.

Contraindications (Must Not Use)

The medicine is contraindicated and must not be used in the following populations:

  • Patients with a known hypersensitivity (allergy) to Cefadroxil, to any cephalosporins, or to any of the product's excipients.
  • Patients with a history of severe reactions to penicillins or any other beta-lactam drugs, due to the risk of cross-allergy.

Conditional or Restricted Use

Use of Sefadol requires caution, monitoring, or dose adjustment in certain groups:

  • Renal Impairment: The dosage must be adjusted for patients with significantly impaired kidney function (creatinine clearance < 50 mL/min/1.73 m^2).
  • Gastrointestinal History: Use requires caution in patients with a history of gastrointestinal disease, particularly colitis.
  • Pregnancy and Lactation: As controlled studies are lacking, the drug should be used during pregnancy only if clearly needed. Caution is required when breastfeeding, as the drug is excreted in human milk.
  • Pediatric Use: While generally eligible, formulations (e.g., capsules) may be unsuitable for children under six years of age; liquid preparations are recommended for this group.

What should I know about interactions with other medicines?

The official interaction profile for Sefadol (Cefadroxil) is structured around its renal elimination pathway and specific pharmacodynamic effects, as documented by government regulatory authorities.

Documented Interactions with Medicinal Products

Interacting Substance/Class Official Interaction Outcome
Probenecid Increases Cefadroxil's plasma concentration (systemic exposure) due to competitive inhibition of renal tubular secretion.
Oral Anticoagulants (e.g., Warfarin) Increased risk or severity of bleeding.
Live Bacterial Vaccines (e.g., Typhoid, BCG) Reduced therapeutic efficacy of the vaccine due to pharmacodynamic antagonism. Co-administration is restricted.
Nephrotoxic Medicinal Products Increased risk of nephrotoxicity with co-administration.
Certain Diuretics (e.g., Acetazolamide, Amiloride) May increase the excretion rate of Cefadroxil, resulting in a lower systemic serum level.

Other Interaction Constraints

The absorption of Sefadol is officially documented as not significantly affected by food, allowing for administration independently of meals. No mandatory timing separation rules are explicitly documented in official labeling for the product.

In the presence of markedly impaired renal function (Creatinine Clearance below 50 mL/min/1.73 m^2), the risk of Cefadroxil accumulation is increased, which may intensify the effect of other interactions. Furthermore, Cefadroxil may cause a positive direct Coombs' test, which is a laboratory procedural interaction that can interfere with hematologic testing.

Mechanism of Action

️ How Sefadol Works

Covalent Inhibition of Bacterial Penicillin-Binding Proteins

The core action of Sefadol is the covalent inhibition of Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for cell construction. By acting as a substrate analogue, the drug's beta-lactam structure permanently binds to and inactivates transpeptidases, thus directly halting the molecular machinery required for bacterial survival. The mechanism targets enzymes exclusive to the bacterial structure, resulting in selective microbial action.


Cascade to Osmotic Lysis via Cell Wall Disruption

Blocking the transpeptidases prevents the cross-linking of peptidoglycan strands, the final step in building the rigid bacterial cell wall. This failure compromises the cell's integrity against its own high internal osmotic pressure, leading to immediate osmotic lysis (cell rupture and death). This sequence defines the drug's bactericidal effect, leading to the irreversible death of susceptible pathogen populations.


️ Mechanistic Constraints from Enzyme Inactivation

The effectiveness of this beta-lactam mechanism is constrained by bacterial resistance strategies, primarily the production of beta-lactamase enzymes. These enzymes chemically destroy the functional beta-lactam ring before it can reach the PBP targets, thereby neutralizing the drug. This limitation means the entire cell wall disruption cascade is aborted, failing to initiate the bactericidal consequence.

Dosage and Administration Information

How to Use Sefadol (Cefadroxil)

The usage protocol for Sefadol focuses on the method of administration, dose ranges, and duration. As a first-generation cephalosporin, Cefadroxil is designated for oral administration. It is available in several strengths, including 500 mg capsules, 1 g tablets, and powder for oral suspension in concentrations such as 250 mg/5 mL.

Standard adult dosing for Sefadol typically falls in the 1 g/day to 2 g/day range, depending on the specific infection being addressed. This total daily dose may be administered either as a single dose once daily or divided into two equal doses taken every 12 hours.

Contextual Administration Guidelines

Administration is generally flexible concerning meals, as Sefadol may be taken without regard to food; however, it is observed that taking it with food may help diminish potential gastrointestinal discomfort.

For the powder for oral suspension, the product must be reconstituted with a specific volume of water and shaken well before each dose. This reconstituted liquid must be stored under refrigeration and discarded after 14 days.

Duration and Special Adjustments

Treatment duration is defined by the type of infection, requiring a minimum course of 10 days for beta-hemolytic streptococcal infections to ensure eradication. In all cases, the medication course is typically continued for two to three days after the clinical signs of the infection have fully resolved. A crucial procedural constraint involves renal impairment: for adults with reduced creatinine clearance, the dosing interval must be extended to prevent drug accumulation, a modification critical for proper use.

Recent Clinical Evidence

Research evidence / Overview of Studies for Sefadol

Evidence from Controlled Trials in Urinary Tract Infections (UTIs)

Research investigating Sefadol (Cefadroxil) for Urinary Tract Infections (UTIs) consists primarily of Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies were conducted to explore how symptoms change over time and to examine the eradication of specific bacteria as a study outcome. Researchers typically evaluated Sefadol in diverse groups, including adults and pediatric patients, with UTIs that were classified as both uncomplicated and complicated. The key outcomes measured were the measurement of clinical cure of the infection and symptom changes linked to inflammatory or irritative states, such as painful urination (dysuria) and urinary urgency, over the short-term treatment period.

Studies report how symptoms evolved in the observed populations, and findings describe patterns observed in the studies related to short-term changes. Findings indicate patterns of bacterial clearance measured when Sefadol was used for the prescribed duration, typically 7 to 14 days. Despite the established research base, long-term effects are not fully established and data remain insufficient regarding comparative studies of Sefadol against newer antibiotic therapies.


Research Findings for Throat and Tonsil Infections

Research exploring Sefadol for pharyngitis and tonsillitis (throat and tonsil infections), particularly those caused by Streptococcus pyogenes, relies on RCTs and Meta-analyses. These trials were applied in research contexts involving fluctuating or unstable symptoms. Studies monitored the microbiological cure (referencing bacterial clearance) and the clinical cure (referencing patient outcomes). The evidence also contributes to understanding symptom patterns by describing the evaluation of Sefadol in the context of avoiding certain subsequent health issues (sequelae), such as rheumatic fever.


What Research Gaps and Uncertainty Remain

Evidence quality varies across studies, particularly for less common uses like infections of the skin and soft tissue, where the data for certain groups remain insufficient, especially for deep or complicated infections. A research gap relates to the availability of contemporary data that compare Sefadol to newer antibacterial agents now available. Furthermore, the evidence base supporting the use of Sefadol as a prophylactic agent for preventing rare infections, such as bacterial endocarditis, is typically derived from low-level evidence based on observational studies and expert consensus.

Key Studies & References

  1. Subacute Bacterial Endocarditis Prophylaxis - StatPearls - NCBI Bookshelf (referencing AHA guidelines)

Frequently Asked Questions (FAQ)

Common questions about Sefadol (FAQ)


Q: Why do some people say Sefadol makes them feel sleepy?

A: Official documentation for Sefadol does not typically list sleepiness as a common side effect. However, the product information notes that some cephalosporin-class antibiotics may rarely be associated with central nervous system effects. These can include reported instances of sleeplessness (insomnia) or, in very rare cases, feelings of dizziness or unusual fatigue.


Q: How long does it usually take for Sefadol to start working?

A: While the time it takes to feel better can vary for each person and infection, patient guidance materials generally state that relief from symptoms often begins during the first few days of taking Sefadol. It is important to remember that feeling better early in the course of treatment does not mean the infection is fully cleared, and the full prescribed course is typically continued as directed.


Q: What should I do if I miss a dose of Sefadol?

A: Official patient information often describes the procedure for a missed dose as taking it as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose is typically skipped to avoid taking too much medicine close together. A double dose is generally not recommended to compensate for the missed one, and the general recommendation is to continue with the regular schedule.


Q: Is it normal to feel a bit dizzy when first starting Sefadol?

A: Dizziness is noted in official drug documents as a rare or very rare reported side effect of Cefadroxil, the active ingredient in Sefadol. It is not listed among the common reactions expected when beginning this medication. If dizziness or any other concerning side effect occurs, contacting a healthcare provider for clarification is recommended.


Q: Does Sefadol interact with common pain relievers like ibuprofen?

A: Official documents advise caution when taking Sefadol with certain types of pain relievers, specifically the class of non-steroidal anti-inflammatory drugs (NSAIDs), such as acetylsalicylic acid. The concern is an increased risk of potential kidney toxicity when these types of medicines are used together. Information for the public often highlights the importance of discussing all medications, including common pain relievers, with a healthcare provider.


Q: What happens if I stop taking Sefadol suddenly?

A: Official guidelines emphasize that the full prescribed course is typically continued, even after symptoms improve. Stopping the medication earlier than the prescribed duration is not usually recommended, as it risks the infection not being completely cleared and can increase the chance of the bacteria developing resistance to the antibiotic.


Q: Can Sefadol affect my mood or energy levels?

A: Mood changes are not typically listed as a side effect in official Cefadroxil documentation. However, in very rare instances, reports have included unusual fatigue or weakness. If persistent changes in energy or mood are noticed, consulting with a healthcare provider for review is a recommended step.


Q: Does alcohol change the effect of Sefadol?

A: Official labeling and interaction profiles for Cefadroxil, the active substance in Sefadol, do not document a specific, direct interaction or incompatibility between the drug and alcohol.


Q: Is there a generic version of Sefadol available?

A: Yes, Sefadol is the brand name, and the active ingredient is Cefadroxil. The medication is widely available under its official generic name from different manufacturers.


Q: Can Sefadol be taken with certain vitamins or supplements?

A: Patient guidelines recommend informing your healthcare provider about all products you use, including vitamins, minerals, herbal products, and dietary supplements. This ensures any potential interactions, even those not formally documented in the primary drug label, can be assessed by your prescriber.


Q: How long does Sefadol stay in your system after the last dose?

A: Official pharmacokinetic data indicates that Cefadroxil is primarily eliminated by the kidneys. Over 90% of the active ingredient is typically excreted from the body in the urine, generally within 24 hours of the last administered dose.


Q: Is Sefadol addictive or habit-forming?

A: Cefadroxil is a prescription antibiotic and is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or other major regulatory bodies. It is not considered to be an addictive or habit-forming medicine.


Q: Why is there a warning about driving while taking Sefadol?

A: Although the official documentation does not contain a specific driving warning, it is common guidance for medications that can cause effects like dizziness or fatigue (which are reported rarely). Patients are generally advised to be aware of how they react to Sefadol before operating a vehicle or heavy machinery.


Q: Does Sefadol interact with birth control pills?

A: Official interaction databases indicate that Cefadroxil may potentially reduce the effectiveness of certain hormonal contraceptives, specifically birth control pills containing estradiol. Individuals using hormonal contraceptives are advised to consult with their prescriber to determine if an alternative or additional method of birth control is needed.


Q: Why do official documents emphasize talking to a doctor before use?

A: Official documents emphasize consulting a physician because Sefadol is a prescription-only drug with certain required safeguards. The prescriber must evaluate individual factors like kidney function, allergies, pre-existing conditions, and potential drug interactions to ensure the medication is used appropriately.


Q: Do I need to take Sefadol at the same time every day?

A: Patient guidance often highlights the benefit of maintaining a consistent administration schedule, such as taking the drug at around the same times every day. This consistency helps maintain a steady level of the antibiotic in the body, which is important for clearing the infection effectively.


Q: Can I crush or split Sefadol tablets?

A: Sefadol is manufactured in several forms, including capsules, tablets, and a powder for oral suspension. The liquid suspension is generally provided for patients, such as children, who have difficulty swallowing tablets. It is generally described that tablets should be taken whole, in line with the product's official administration form.


Q: Can Sefadol cause problems with sleep or insomnia?

A: Official documentation lists sleeplessness (insomnia) as a very rare reported side effect of Cefadroxil. If persistent issues with sleep are experienced while taking Sefadol, contacting a healthcare provider for review is recommended.


Q: If I have liver problems, can I still take Sefadol?

A: Official documentation notes that rare adverse reactions can include minor transaminase elevations and, very rarely, hepatic dysfunction (liver issues). Caution is necessary, and liver function may need to be monitored by a healthcare provider, particularly if pre-existing liver conditions are present.


Q: What do I do if a side effect of Sefadol is bothering me?

A: If any side effects become severe or do not go away, or if serious symptoms occur (like a severe allergic reaction or severe diarrhea), it is important to contact a healthcare provider or seek emergency medical help immediately. For non-severe but bothersome side effects, consultation with a prescriber may be necessary.

How should Sefadol be stored and disposed of?

How to Store and Dispose of Sefadol

Sefadol (Cefadroxil) requires distinct storage conditions based on its formulation to maintain stability.

Storage Requirements

Product Form Temperature Requirement Stability Constraint
Unmixed Product (Dry Powder, Tablets) Controlled Room Temperature (20 C to 25 C) Must be kept in the original, tightly closed container and protected from moisture. Do not refrigerate.
Reconstituted Suspension (Liquid) Refrigerate (2 C to 8 C) Usable for 14 days under refrigeration; discard any remainder after this period. Do not freeze.

Handling and Disposal

All forms must be stored out of the sight and reach of children to prevent accidental ingestion. Unused or expired Sefadol should be disposed of via an official drug take-back program. If one is unavailable, follow the official procedure of mixing the product with an undesirable substance before discarding it in the household trash. Personal identifying information must be removed from the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sefadol found in:

A-Z Index: